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Abstract
Background: Molecular networks represent the backbone of molecular activity within cells and provide
opportunities for understanding the mechanism of diseases. While protein-protein interaction data constitute static
network maps, integration of condition-specific co-expression information provides clues to the dynamic features
of these networks. Dilated cardiomyopathy is a leading cause of heart failure. Although previous studies have
identified putative biomarkers or therapeutic targets for heart failure, the underlying molecular mechanism of
dilated cardiomyopathy remains unclear.
Results: We developed a network-based comparative analysis approach that integrates protein-protein interactions
with gene expression profiles and biological function annotations to reveal dynamic functional modules under
different biological states. We found that hub proteins in condition-specific co-expressed protein interaction
networks tended to be differentially expressed between biological states. Applying this method to a cohort of
heart failure patients, we identified two functional modules that significantly emerged from the interaction
networks. The dynamics of these modules between normal and disease states further suggest a potential
molecular model of dilated cardiomyopathy.
Conclusions: We propose a novel framework to analyze the interaction networks in different biological states. It
successfully reveals network modules closely related to heart failure; more importantly, these network dynamics
provide new insights into the cause of dilated cardiomyopathy. The revealed molecular modules might be used as
potential drug targets and provide new directions for heart failure therapy.
Background
Protein-protein interactions (PPI) are of central impor-
tance for most biological processes, and thus the protein
interaction network (PIN) provides a global picture of
cellular mechanisms. With the accumulation of interac-
tome and transcriptome data, the integration of gene
expression profiles has revealed the dynamics of protein
interaction networks. For example, Han et al. [1] ana-
lyzed the protein interaction network of yeast and
uncovered two types of hub proteins: “party” hubs and
“date” hubs, which displayed condition- or location-
specific features in the interactome network. Xue et al.
[2] developed a new analytic method to discover the
dynamic modular structure of the human protein inter-
action network in their aging study. Recently, Taylor et
al. [3] also proposed another two types of hub proteins:
intermodular hubs and intramodular hubs, and identi-
fied whether the interactions between proteins were
context specific or constitutive in the human protein
interaction network. Similar techniques were also
applied to reveal disease related genes or modules.
Chuang et al. [4] improved the prognostic predictive
performance of gene expression signatures by incorpor-
ating interactome data in breast cancer. Taylor et al.[ 3 ]
used a method analogous to a previous study [1] and
revealed that dynamic modularity of the human protein
interaction network may be a good indicator of breast
cancer prognosis. In the context of heart failure,
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profiles with the protein interaction network in human
dilated cardiomyopathy and efficiently identified poten-
tial novel DCM signature genes and drug targets. These
studies suggest that the integration of interactome data
with transcriptome information may facilitate the identi-
fication or discovery of disease biomarkers.
Heart failure is one of the main causes of death in the
world and is the consequence of many complex factors
including genetics, diet, environment and lifestyle. Heart
failure is a physiological state in which the heart cannot
provide sufficient output of blood to meet the body’s
needs. Dilated cardiomyopathy (DCM), the major cause
of heart failure, impairs the blood pumping ability of the
heart and leads to insufficient blood flow to vital organs
due to the enlargement and weakening of the heart [7].
Previous studies [8-10] on gene expression profiles have
provided distinct perspectives on the etiology of DCM.
Barth et al. [8] pointed out the significant immune
response processes involved in end-stage DCM and pre-
sented a robust gene expression signature of this dis-
ease. Wittchen et al. [10] suggested novel therapeutic
t a r g e t sb yg e n ee x p r e s s i o np r o f i l ea n a l y s i so fh u m a n
inflammatory cardiomyopathy. Kabb et al. [9] analyzed
microarray dataset of human myocardial tissue to obtain
region- and DCM-specific transcription profiles and
determined the gene expression fingerprint of DCM.
Even though various causes of DCM have been revealed,
the underlying molecular mechanism of this disease
remains unclear.
Here, we developed a network-based analysis approach
to discover DCM or non-DCM related functional sub-
networks by integrating DCM related gene expression
profiles with the human protein interaction network and
Gene Ontology (GO) annotations. A comparative analy-
sis was utilized to extract DCM exclusive subnetworks
as heart failure related modules. These modules could
be used to classify normal and disease samples. We
further investigated the co-expressed protein interaction
network structures of each module for DCM and non-
DCM and observed dynamic variations of the identified
modules between the two states. Our results suggest
that the modular changes between DCM and non-DCM
could imply plausible molecular mechanisms involved in
heart failure progression.
Results
Condition-Specific Co-expressed Protein Interaction
Networks
We integrated gene expression profiles with the protein
interaction network to construct condition-specific co-
expressed protein interaction networks of DCM and
non-DCM, respectively. Two interacting proteins are
called co-expressed protein-protein interaction (CePPI)
under a specified condition,i ft h e i re n c o d i n gg e n e sa r e
expressed correlatively with each other under particular
biological conditions, such as DCM or non-DCM in this
study. The network that consists of all the CePPIs under
the DCM condition is abbreviated as DCM CePIN and
the network under the non-DCM condition as non-
DCM CePIN. Table 1 summarizes the structural infor-
mation of DCM and non-DCM networks. Given that
the gene expression profiles were derived from the same
tissue [8], DCM and non-DCM CePINs shared almost
70% of proteins and nearly 80% of physical protein
interactions in common. However, the shared CePPIs
were only approximately 30%, indicating a large amount
of interaction rewiring between DCM and non-DCM.
Hence, CePPIs may reveal the condition-specific
dynamic information hidden among otherwise common
static interactions. Previous studies [1,11] have shown
that by integrating co-expression information into physi-
cal protein interaction networks, dynamic features
among various networks can be extracted. This preli-
minary observation of the network structure indicates
the limitation of a static protein interaction network,
and demonstrates the necessity of applying a condition-
specific co-expressed protein interaction network model
to discover the dynamic features which are attributed to
the changes in gene expression profiles inside the static
biological networks.
Hub Proteins in CePINs Tend to Be Differentially
Expressed
To further investigate the features of condition-specific
CePINs, we examined their topological properties,
including degree, betweenness centrality, closeness cen-
trality and clustering coefficient for significantly differ-
entially expressed genes (SDEGs). All four topological
properties of SDEGs were significantly higher than those
of non-SDEGs in DCM CePIN, as well as non-SDEGs in
non-DCM CePIN (Table 2). The results showed that the
proteins encoded by differentially expressed genes under
a specific biological condition tended to play topologi-
cally important roles in the corresponding CePINs. Fig-
ure 1A shows that proteins with higher CePPI degrees
have larger proportions of SDEGs. However, due to the
fact that hub proteins in static PIN had higher CePPI
degrees in condition-specific CePINs, we examined high-
and low-degree proteins in three types of networks
Table 1 Structural information of DCM and non-DCM
networks
Proteins PPIs Co-expressed PPIs
DCM 3160 13928 4306
non-DCM 3302 14557 4872
Overlap 2226 11092 1425
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(Figure 1B). Although the proportion of SDEGs (50%) for
high-degree proteins in static PIN was similar to those
with a low-degree (46%), SDEGs were especially enriched
for high-degree proteins in both DCM CePIN and non-
D C MC e P I N( >6 0 % )i nc o m p a r i s o nw i t hl o w - d e g r e e
proteins (Fisher’s exact test, P < 0.001). The results
implied that hub proteins in CePINs are more likely to
be differentially expressed, suggesting modular rewiring
of co-expressed interactions between different biological
states. Altogether, the condition-specific CePINs could
carry more biologically significant network structure that
reflects the underlying gene expression dynamics.
Hub proteins of DCM CePIN were also studied in the
context of Gene Ontology to identify major biological
roles in each protein category. Table 3 shows the top 10
significantly over-represented functional annotations of
DCM hub proteins in GO biological process category
(level 6) by BiNGO [12] (Hypergeometric test, Benjamini
& Hochberg FDR correction, P ≤ 0.01). Previously,
Camargo and colleagues [6] analyzed the differentially
expressed genes of DCM in the context of GO and
identified phosphorylation to be significantly over-
represented, which is also the most significant functional
annotation of hub proteins in DCM CePIN from our
study. Kang and colleagues [13] suggested that DCM is
highly associated with dysfunction of apoptosis pathways.
Consistent with their study, apoptosis-related functions,
including regulation of apoptosis, apoptosis, and positive
regulation of programmed cell death, came up in our GO
identification. These findings were consistent with what
has been observed in previous studies and imply that hub
Table 2 Comparison of key topological properties
DCM CePIN
Property SDEGs Non-SDEGs P-value
Degree 3.47 2.51 9.58E-09
Betweenness centrality 0.0023 0.0012 1.79E-07
Closeness centrality 0.1769 0.1734 4.50E-03
Clustering coefficient 0.04 0.03 2.23E-04
Non-DCM CePIN
Degree 3.72 2.6 7.64E-15
Betweenness centrality 0.0021 0.0011 8.79E-15
Closeness centrality 0.1837 0.1796 1.64E-04
Clustering coefficient 0.04 0.03 1.81E-07
The average of each topological property for SDEGs and non-SDEGs in either
DCM or non-DCM CePIN is given in the table together with the corresponding
P-value. The P-values were calculated using non-parametric Wilcoxon rank-
sum tests.
Figure 1 Correlations between CePPI degree and SDEG proportion. (A) The line chart shows that the proportion tendencies of SDEGs in
terms of degree are positively correlated in DCM and non-DCM CePINs. (B) The bar chart displays the SDEG proportions for proteins with high-
(top 50%) and low-degree (last 50%) in each network; DCM CePIN, non-DCM CePIN and static PIN. Both DCM and non-DCM CePINs represent
significant differences of SDEG proportions between high- and low-degree proteins. The results indicate that the SDEG proportions are positively
correlated with the CePIN degree rather than the static PIN.
Table 3 Top 10 significant level-6 GO annotations of
hubs
GO term Description P-value
16310 phosphorylation 2.40E-12
7167 enzyme linked receptor protein signaling pathway 3.01E-10
6464 protein modification process 7.28E-08
42981 regulation of apoptosis 1.41E-05
6915 apoptosis 2.09E-05
31325 positive regulation of cellular metabolic process 2.79E-05
43068 positive regulation of programmed cell death 4.35E-05
48340 paraxial mesoderm morphogenesis 4.95E-05
48339 paraxial mesoderm development 4.95E-05
45941 positive regulation of transcription 9.67E-05
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their biological roles.
Identification of Two DCM-Related Functional Modules
Based on the condition-specific CePINs, we propose a
new analysis approach to identify condition-specific
functional modules. First, for any specific biological con-
dition under study, we selected significantly enriched
functions among proteins in condition-specific CePIN.
For each enriched function, hypergeometric tests were
performed to examine whether the co-expressed interac-
tions between two common-function proteins are also
significantly enriched. By applying the proposed analysis
to DCM and non-DCM CePINs, two functional mod-
ules; muscle contraction and organ morphogenesis, were
specifically revealed for DCM, as shown in Figure 2.
Table 4 shows the information of the network structure,
hypergeometric test results, and classification accuracy
of these two modules, respectively. Both modules can be
used to discriminate DCM from normal tissue samples
with a classification accuracy of 0.79 (muscle contrac-
tion) and 0.86 (organ morphogenesis). We further
assessed their classification performance using receiver
operator characteristic (ROC) curves and tested these
with the expression profiles (GSE4172) from another
cohort of DCM patients. The expression levels of the
genes in each module were averaged to compute a
module activity score. This revealed typical area under
curve (AUC) values of 0.75 ~ 0.90 as shown in Figure 3.
These results indicate that the identified two modules
might serve as potential therapeutic targets of DCM.
To reveal connections between member genes in both
modules, their gene co-expression networks were stu-
died and visualized in Figure 4. Both networks were
organized with dense structure. The expression profiles
of member genes in each module correlated more signif-
icantly with each other than those in random subnet-
works of equal size (organ morphogenesis: 0.47 versus
0.36 for averaged PCC, Z =5 . 1 ,P < 0.001; muscle con-
traction: 0.45 vs. 0.36, Z = 2.62, P = 0.06). These results
suggest that strong connections within each module
exist at the transcriptional level.
Subsequently we compared conditional gene expres-
sion levels and correlations of gene co-expression
between DCM and non-DCM samples to illustrate the
Figure 2 Visualization of the identified DCM-related modules. (A) Muscle contraction and (B) organ morphogenesis. Down-regulated SDEGs
are represented by green nodes, up-regulated SDEGs by red nodes and non-SDEGs by grey nodes. Edges represent the physical interactions
between proteins in HPRD PIN. Co-expressions are represented by red edges and anti-expressions by green edges.
Table 4 Summary of the two identified DCM-related
modules
Module Node Ep Edge Dp Accuracy AUC
Muscle contraction 21 0.016 18 0.008 0.79 0.76
Organ morphogenesis 43 0.017 34 0.007 0.86 0.89
The list includes numbers of nodes and edges, hypergeometric test results
(Ep: P-value for functional enrichment; Dp: P-value for functional dyad
enrichment) and classification performance (accuracy and AUC).
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independent gene expression profiles: (A) GSE3586, and (B) GSE4172. OM: organ morphogenesis; MC: muscle contraction.
Figure 4 Co-expression networks of the identified DCM-related modules. Visualization of co-expression networks of (A) muscle contraction
and (B) organ morphogenesis modules. Co-expressed protein-protein interactions are represented by red edges and other co-expressed gene
pairs by green edges.
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found that the average expression levels of member
genes in each module changed between two conditions
by an amount larger than expected from random sub-
networks of equal size (organ morphogenesis: 0.59 vs.
0.39 for average gene expression difference, Z = 2.58,
P = 0.01; muscle contraction: 0.58 vs. 0.39, Z = 1.7, P =
0.06). Moreover, the average change of member PPI
gene expression correlation between conditions were
also significantly higher (organ morphogenesis: 0.58 vs.
0.44, Z = 2.56, P = 0.01; muscle contraction: 0.56 vs.
0.44, Z = 1.75, P = 0.05).
Figure 5B shows that gene pairs associated with PPIs
in the organ morphogenesis module were more strongly
correlated in DCM than in non-DCM, implying its acti-
vation in DCM. Meanwhile, in the muscle contraction
module, gene pairs with PPIs were strongly correlated in
both DCM and non-DCM (see Figure 5A, histogram),
indicating that it is activated in both DCM and non-
DCM. Nonetheless, the CePPIs of muscle contraction
module in DCM were quite different from that in non-
DCM (see Figure 5A, scatter plot), suggesting that genes
in the muscle contraction module changed their asso-
ciated partners between non-DCM and DCM. Although
the muscle contraction module was not significantly dif-
ferentially expressed and activated in both DCM and
non-DCM, it was still discovered by our method due to
its diverse CePPIs between DCM and non-DCM. There-
fore, the muscle contraction module would have been
omitted if the transcriptomic data were not integrated
into the interactome data to study the condition-specific
PPIs or CePPIs.
We further studied the largest connected components
of these two modules with respect to the co-expressed
protein interaction difference between DCM and non-
DCM to determine their dynamic features. In the mus-
cle contraction module, DTNA, SNTA1, SNTB1, and
DMD were shown to be highly correlated with each
other in non-DCM CePIN, but not in DCM CePIN (see
Figure 6A). Proteins encoded by DTNA, SNTA1, and
SNTB1 are components of the cytoplasmic part of dys-
trophin-associated protein complex (DAP) [14]. In addi-
tion, pivot proteins in both non-DCM and DCM, which
have relatively more co-expressed interacting partners,
were observed to change from DTNA and DMD to
UTRN.
Similar dynamic features were also observed in the
organ morphogenesis module.W er o u g h l yd e f i n e dt h i s
module into two major regions: the upper diamond,
formed by INSR, CRKL, IGF1R and RASA1, and the
bottom triangle, by FLT1, NRP2 and NRP1 (see Figure
6B). From the results, it is evident that the communica-
tion between the diamond and the triangle in DCM
CePIN was bridged by KDR and CTNNB1, but
disconnected in non-DCM CePIN. Moreover, the
diamond structure in non-DCM CePIN was observed to
have collapsed. These changes in the muscle contraction
and organ morphogenesis modules may hold some clues
to the progression of DCM.
Discussion
Protein-protein interaction networks cover all possible
interactions regardless of when or where the interaction
takes place. In this sense, they are static. By integrating
gene expression profiles of DCM with human protein-
protein interaction networks, we successfully extracted
two co-expressed protein interaction networks (CePINs),
i.e. DCM and non-DCM. Here, we showed that DCM
and non-DCM CePINs exhibit substantial differences in
co-expressed protein-protein interactions, even though
their network structures are similar. The differences
may be attributed to gene expression variations and
interaction rewiring between DCM and non-DCM con-
ditions. We suggest that CePINs are able to reveal con-
dition-specific interactions and the dynamic features
hidden in static protein-protein interaction networks.
Next, we showed that hub proteins in CePINs tended
to be SDEGs compared to non-hub proteins. In CePINs,
proteins with higher degrees imply that they have more
direct interacting partners co-expressed in gene expres-
sion levels; therefore any significant modification in
their expression levels might influence more interacting
partners. This observation suggests that once gene
expression of hub proteins is changed, it is expected to
cause greater expression variations to its neighboring
interaction network in DCM.
Since our analysis relies on PCC calculated from gene
expression data to define CePPIs and construct condi-
tion-dependent networks, we have carried out some
further examinations about its robustness. First, we per-
formed the same analysis with tightened PCC threshold,
P < 0.01, and obtained consistent results (see Table S1 -
S4, Figure S1 - S2 in Additional File 1). Second, Li et al.
[15] recently revealed that correlations of gene expres-
sion levels to disease states could vary a lot with ran-
domly selected subsets of the samples from one single
microarray data set. Under this light, we have performed
re-sampling of our gene expression data and found that
both the recovery rate of CePPIs and the identification
rates of the two DCM-related modules decreased as we
lowered the sample size (Figure S3 - S4 in Additional
File 1). However, the identification rates of the two
DCM-related modules were much higher than any other
modules, indicating that these two identified modules
were robustly related to DCM.
Since the human PPI data are still incomplete and
noisy, there are different curated collections of human
PPI data available. To examine whether our analysis was
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Page 6 of 14robust against the PIN we used, we performed the same
analysis with an expanded PIN integrating the PPI data
from HPRD [16] and BioGRID [17] databases and
obtained consistent results (see Table S5 - S8, Figure S5
- S6 in Additional File 1).
One of the major symptoms of heart failure is the
inability of the heart to sufficiently supply blood flow to
the rest of the body. This is strongly related to heart
muscle contraction efficiency. The failing heart under-
goes morphological changes and becomes weakened and
enlarged in DCM, the most common form of cardio-
myopathy. Our findings in DCM-related modules of
muscle contraction and organ morphogenesis were con-
sistent with the known symptoms of cadiomyopathy.
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Figure 5 Analysis of CePPI variations in the identified DCM-related modules. Scatter plots (left) and histograms (right) for PCC values of
PPIs in muscle contraction and organ morphogenesis modules in DCM and non-DCM respectively, are shown. In the scatter plot, each dot
presents a PPI in the modules; red and green dots represent PPIs with significant correlations (PCC ≥ 0.5 or PCC ≤ -0.5) in DCM and non-DCM
samples respectively; green dots with red border represent PPIs with significant correlations in both DCM and non-DCM samples. In the
histograms, x-axis represents the categories of PCC and y-axis the frequency (proportion). In addition, green and red lines display the frequencies
of PCC for non-DCM and DCM PPIs contained in the modules. (A) Muscle contraction. (B) Organ morphogenesis. Figure 5B suggests that the
organ morphogenesis module is more activated in DCM samples, since in the scatter plot, there are more dots of CePPIs for DCM distributed on
the significant area than for non-DCM and histogram of DCM also expands to two significant areas than non-DCM. On the other hand, Figure
5A suggests that the muscle contraction module is activated in both non-DCM and DCM samples, because these two distributions for non-DCM
and DCM have a high degree of overlap in the histogram. However, the red dots in the scatter plot do not significantly overlap with the green
dots, suggesting that these two distributions are produced by different CePPIs.
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ules in relation to the underlying molecular mechanisms
of dilated cardiomyopahty.
In the muscle contraction module, three SDEGs,
DMD, DTNA and UTRN, form a closed loop, implying
topological significance. Dystrophin, encoded by DMD,
is a recessive, fatal X-linked disorder. It appears to stabi-
lize the sarcolemma and protects muscle fibers from
long-term contraction-induced damage and necrosis
[18], though its precise roles at the cellular level are still
to be elucidated. Dystrobrevin-alpha, encoded by
DTNA, belongs to the dystrobrevin subfamily of the
dystrophin family and is a component of the dystro-
phin-associated protein complex (DAP) [14]. Disruption
of DAP is associated with various forms of muscular dys-
trophy. Dystrophin binds to the intracellular cytoskeleton
by associating with actin filaments at its N-terminus,
whereas at its C-terminus dystrophin interacts
with members of the DAP, such as b-dystroglycan, which
is encoded by DAG1. Dystrophin therefore links the
Figure 6 Dynamic features of the identified DCM-related modules. Dynamic features within these two DCM-related modules are expressed
by the alternation of CePPIs in non-DCM and DCM conditions. (A) Muscle contraction. Hubs of this module are DMD and DTNA in non-DCM,
but are changed to UTRN in DCM. (B) Organ morphogenesis. As the condition shifted from non-DCM to DCM, the connection is rebuilt by the
interaction made from KDR and CTNNB1.
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series of linking proteins in the cell membrane, and
hence to the extracellular matrix [19]. In the muscle con-
traction module, both DMD and DTNA were signifi-
cantly down-regulated. The absence of dystrophin was
suggested to cause the collapse of the entire DAP and
plasma membrane, leading to muscle damage [14]. On
the other hand, mutations of DTNA are associated with
left ventricular non-compaction with congenital heart
defects [20]. These defects might lead to cardiac muscle
damage and possibly DCM.
Utrophin encoded by UTRN shares both structural
and functional similarities with the dystrophin gene.
Mouse studies suggested that utrophin may serve as a
functional substitute for the dystrophin gene and can be
viewed as a rescue protein in muscular dystrophy caused
by abnormal dystrophin expression [21]. In our results,
UTRN was significantly up-regulated, which might illus-
trate the rescue action of utrophin in the absence of
dystrophin. However, no protein-protein interactions
exist or are found between UTRN and ACTC1, which
encodes the actin in cardiac cells, suggesting that pro-
gressive heart failure could be due to the failure of
UTRN rescue. Based on these results, we proposed a
hypothesis to explain how the muscle contraction mod-
ule affects DCM progression (Figure 7). Recently,
Bostick a n dc o l l e a g u e s[ 2 2 ]r e p o r t e dt h a tu t r o p h i nu p -
regulation alone (without dystrophin expression) leads
to DCM in mice, which provides strong evidence in
support of our hypothesis.
On the other hand, in the organ morphogenesis mod-
ule, we noticed that the largest connected component
contains two major clusters. The two major clusters
consisted of insulin pathway-related genes, including
IGF1R (insulin-like growth factor 1 receptor) and INSR
(insulin receptor) and vascular endothelial growth factor
(VEGF) pathway-related genes, including FLT1
(VEGFR1), NRP1, NRP2 and KDR (VEGFR2). These
two pathways have both been reported to be important
in cardiac remodeling [23]. Proper IGF1R and INSR sig-
naling plays an essential role in cardiac function, and
the disruption of this signaling induces the onset of
DCM in knockout mice [24,25]; while the VEGF path-
way is crucial in vasculogenesis and angiogenesis, which
was reported to be altered in DCM [26]. The significant
up-regulation of these two clusters of genes can there-
fore signify autosomal repair for damage caused by
hypoxia induced by early DCM symptoms. Malfunction
of these activated pathways are possible reasons for the
disease progression.
With focus on these pathways, we compared the sub-
networks in DCM and non-DCM patients and found
several notable points. First, these two clusters were not
independent from each other, but were linked by a
string of genes: RASA1, KDR, CTNNB1, and FLT1.
RASA1, encoding p120-RasGAP which activates RAS
GTPase, is best known for its negative regulation of the
RAS/MAPK pathway downstream of several growth fac-
tor pathways responsible for cell proliferation, including
the IGF-1, insulin and VEGF pathway. Proper activation
of the RAS-dependent pathway is important for the
functions of these pathways. The up-regulation and the
linkage between RASA1 and INSR may infer a possible
negative regulation of the Ras-dependent pathway. We
Figure 7 Hypothesis of the underlying molecular mechanism of DCM. In a normal myocardium cell, the dystrophin encoded by DMD
builds a link between the intracellular microfilament network of actin and the dystrophin-associated protein complex (DAP) to protect the
myocardium from long-term contraction-induced damage and necrosis. In the left panel, down-regulation of dystrophin (green rod-shaped
protein) causes the collapse of the DAP and plasma membrane, leading to myocardium damage and possibly heart failure. To rescue this defect,
utrophin (red rod-shaped protein) encoded by UTRN, which is the functional substitute for dystrophin, is up-regulated, as shown in the right
panel. However, utrophin (UTRN) could not bind to the actin ACTC1 in cardiac cells. Hence, the connection between the actin and DAP is
broken, leading to the disassociation of the DAP. As a result, cardiac cell membranes become permeable and gradually lyse, resulting in tissue
destruction and heart failure.
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activation, to be significantly down-regulated in DCM
patients. These observations imply the negative regula-
tion of growth factor signaling involving insulin and
insulin-like growth factor. Second, the down-regulation
of CTNNB, which encodes beta-catenin in VE-cadherin
essential for contact inhibition of VEGF-induced prolif-
eration [26,27], infers a malfunction in the control
of VEGF-induced vasculogenesis. The failure of beta-
catenin regulation and defective vascularization have
been observed in idiopathic DCM [26].
Our findings regarding the organ morphogenesis mod-
ule successfully revealed possible integration of two
important pathways in DCM and the crucial role that
RASA1 up-regulation and CTNNB1 down-regulation
might play in the etiology of DCM.
Conclusions
Altogether we have developed a network-based com-
parative analysis approach that integrates protein-
protein interactions with gene expression profiles and
biological function annotations to reveal dynamic func-
tional modules under different biological states. Applica-
tion to DCM reveals two functional modules with
dynamic features accountingf o rt h eu n d e r l y i n gd i s e a s e
mechanisms. The revealed molecular modules might be
used as potential drug targets and provide new direc-
tions for heart failure therapy.
Methods
Protein Interaction Network and Expression Data
The human protein interaction network (PIN) was
downloaded from Human Protein Reference Database
(HPRD) [16], and only the largest connected compo-
nent, containing 9,059 proteins and 34,869 interactions,
was studied.
The gene expression data of DCM were retrieved from
Gene Expression Omnibus (GEO), accession number
GSE3586 [8], containing 37,530 genes and 28 samples
(13: DCM, 15: non-DCM) in total, with 6,475 genes
involved in HPRD PIN. Another set of expression pro-
files of DCM was retrieved from GEO accession number
GSE4172 [10] to evaluate the classification performance
of identified modules.
Co-expressed Protein Interaction Networks
To obtain the condition-specific information, an auxiliary
network, called the co-expressed protein interaction net-
work (CePIN) was constructed. This procedure involved
several data integration and search steps for extracting
CePINs from HPRD PIN (or called “static” PIN as
opposed to condition-specific CePIN), as outlined in
Figure 8. Correlation of gene expression profiles between
each pair of interacting proteins in PIN is evaluated by
Pearson correlation coefficient (PCC).
PCC of paired genes (X and Y), which encode inter-
acting proteins in PIN, is defined as:
PCC X Y
n
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where n is the number of condition-specific samples;
Exp(X,i)(Exp(Y,i)) is the expression level of gene X (Y)
in the sample i under a specific condition (DCM or
non-DCM); Exp X () ( Exp Y () ) represents the average
expression level of gene X (Y) and s(X) (s(Y)) represents
the standard deviation of expression level of gene X (Y).
Larger absolute values of PCC indicate higher correla-
tion between evaluated gene pairs. Those with a P-value
of less than or equal to 0.05 were considered as signifi-
cantly correlated. Protein-protein interactions between
proteins encoded by significantly correlated gene pairs
are defined as co-expressed protein-protein interactions
(CePPIs). Based on this definition, the co-expressed pro-
tein interaction network (CePIN) is defined as the set of
CePPIs. Note that we defined CePPI as co-expression in
gene expression levels instead of protein concentrations
since we were lack of the corresponding proteome data.
Although a gene expression level cannot always repre-
sent its protein concentration, previous studies have
observed notable correlations between them [28]. If pro-
teome data are available, the same analysis procedures
described here can be applied with replacement of
Exp(X) and Exp(Y) by protein concentrations.
Significantly Differentially Expressed Genes and Hub
Proteins
Significantly differentially expressed genes (SDEGs) were
determined by Wilcoxon rank sum test (P ≤ 0.05, DCM
against non-DCM). Up-regulated and down-regulated
SDGEs were defined as genes expressed significantly
higher or lower respectively in DCM than in non-DCM.
DCM hub proteins were defined as nodes involved with
more than 23 DCM CePPIs, since these proteins were
among the top 1% of the CePPI degree distribution of
the DCM CePIN.
Topological Analysis of Networks
Four topological measures were used in this analysis:
degree, betweenness centrality, closeness centrality and
clustering coefficient [29]. The degree is the number of
observed interactions of a given protein. Betweenness
centrality (BC) measures the importance of a specific
Lin et al. BMC Systems Biology 2010, 4:138
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Page 10 of 14Figure 8 Flow diagram of the proposed integrative network analysis procedure. Flow diagram of discovery DCM related modules from
static PIN by integrating gene expression profiles. In static PIN, each PPI was assigned a correlation derived from Pearson correlation coefficient
between paired genes engaged in a PPI. Then, CePPIs and PPIs with significant correlations were utilized to construct the CePINs which were
extracted from the static PIN. Next, gene sets which are provided with significant functional enrichment in GO annotation categories were
grouped and isolated from CePINs. Finally, functional subnetworks which were only involved in DCM CePIN were treated as candidate DCM
related modules. In addition, only candidate DCM related modules with GO annotations of levels ≥ 5 were considered as DCM related modules.
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Page 11 of 14protein i in relating any paired proteins in PIN, and is
defined by:
BC
SP
C
i
i
N =
2
,
where SPi is the number of shortest path pass through
protein i and N represents the number of proteins in
PIN. Closeness centrality (CC) represents how close an
evaluated protein is relative to all the others and is
defined as the reciprocal of the mean of the shortest
path lengths (SPLi )f r o mp r o t e i ni to the rest of pro-
teins in PIN,
CC
SPL
i
i
=
1
.
Higher closeness centrality implies shorter distance
between the evaluated protein and all the other proteins
in PIN. The clustering coefficient (C) of a protein deter-
mines how frequently its interacting partners interact
with each other and is defined by:
C
e
C
i
NB
NB
i
i =
2
|| ,
in which eNB is the number of observed interactions
between interacting partners of protein i,a n d| NBi|
represents the number of its interacting partners. C
NBi
2
||
gives the number of all possible interactions among its
interacting partners. In this study, only the largest con-
nected component of each CePIN was considered.
Identification of Condition-Specific Functional Modules
To identify heart failure related modules, we applied a
comparative analysis of CePINs. This analysis included
several steps of functional module discovery and selec-
tion, as illustrated in Figure 8. First, GO annotation was
utilized to choose gene sets, which are involved in DCM
(or non-DCM) CePIN, with significant enrichment of
functional categories in biological process ontology (P ≤
0.05). The P-value of functional enrichment is deter-
mined by a hypergeometric test. The hypergeometric
distribution is described as follows:
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X denotes the evaluated functional category in GO. N
represents the number of GO annotated genes, which
appeared in our microarray data as well as in HPRD
PIN, while m represents that in DCM or non-DCM
CePIN. n represents the number of genes which are
annotated as the evaluated GO functional category in
HPRD PIN. Thus, this formula calculated the probability
of the evaluated functional category that had k genes in
CePIN. The calculated P-value is then adjusted by
applying the Benjamini and Hochberg multiple testing
procedure [30] to control the false discovery rate (FDR)
at significance level of 0.05.
To further retain significantly denser functional sub-
networks, we tested the functional homogeneity of each
significant functionally enriched gene sets in respect to
CePPIs. For this purpose, we defined functional dyads as
paired proteins that formed CePPIs and shared common
biological process as annotated by GO. The significance
of the functional subnetwork is determined by P-value
(≤ 0.05) derived from a modified hypergeometric test:
PX k
m
k
Nm
nk
N
n
ee
e
e
ee
ee
e
e
() , ==
⎛
⎝
⎜
⎞
⎠
⎟
−
−
⎛
⎝
⎜
⎞
⎠
⎟
⎛
⎝
⎜
⎞
⎠
⎟
e is the abbreviation of the functional dyad. Each sym-
bol represents the same meaning with the previous one
in the original hypergeometric test, but the counting tar-
gets are changed from functional genes to functional
dyads. The same multiple testing procedure is per-
formed to adjust the P-value.
After these two tests, only subnetworks with signifi-
cantly high functional homogeneity in both genes and
interactions would be kept for follow-up comparative
analysis in order to reveal candidate DCM related mod-
ules. We defined FDCM_candidate as the set including all
GO annotations of significantly denser functional sub-
networks in DCM and Fnon-DCM_candidate in non-DCM.
Then, FDCM_exclusive could be defined as the difference
between Fnon-DCM_candidate and FDCM_candidate:
FF F DCM exclusive DCM candidate non DCM candidate __ _ =− −
Functional subnetworks mapped in FDCM_exclusive will
be designated as candidate DCM related modules. For
functional specificity, only candidate DCM related mod-
ules with GO annotations greater than or equal to level
5 were considered as DCM related modules.
Evaluation of Classification Accuracy
Hierarchical clustering was used to group samples into
two categories (i.e. DCM or non-DCM) according to the
gene expression levels of members in each module.
Gene expression distance between different samples was
Lin et al. BMC Systems Biology 2010, 4:138
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Page 12 of 14calculated by Euclidean distance. The classification tree
produced by hierarchical clustering was separated at the
root into two groups (sub-trees). The group with more
DCM samples is defined as positive and the other group
is negative. The number of DCM samples in the positive
group is defined as true positive (TP) and the number of
non-DCM samples clustered into this group is false
positive (FP). The number of non-DCM samples in the
negative group is defined as true negative (TN) and the
number of the rest DCM samples is false negative (FN).
They were used to evaluate sensitivity ( TP
TP FN +
)a n d
specificity ( TN
FP TN +
). Then, accuracy was calculated by
Sensitivity Specificity
Number of samples
+ and was used to measure the
classification ability of each module. The receiver oper-
ating characteristic curve (ROC) was obtained according
to the module activity score of each sample, which was
defined as the average expression level of all member
genes in the module.
Additional material
Additional file 1: Supplementary information. This file contains the
robustness analysis of our results in different thresholds of PCC, sample
sizes of gene expression profiles, and protein interaction network.
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